Shanghai Pharmaceuticals Holding Co., Ltd (SHA: 601607)
China flag China · Delayed Price · Currency is CNY
20.91
-0.23 (-1.09%)
Nov 13, 2024, 3:00 PM CST

Shanghai Pharmaceuticals Holding Company Description

Shanghai Pharmaceuticals Holding Co., Ltd. engages research, development, manufacture, distribution, and retailing of pharmaceutical and healthcare products in China and internationally.

The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including digestive system, immune metabolism, motor neuron disease, endocrinology, cardiovascular, psychoneurotic, neoplasm, autoimmunity, systemic anti-infection, mental nerve, anti-tumor, oncology, respiratory system, nervous system, auto-immunity, hypertension, neuromyelitis, diabetes, anticholinesterase, polypeptide hormones uterine tonic, antihistamine, anti-inflammatory, anesthetic, immunomodulatory, antiviral, reflux esophagitis, analgesics, weight management, malignant peritoneal effusion, ulcerative colitis, myasthenia gravis, burn injury, anticoagulant, anti-epileptic, anticonvulsant, Alzheimer’s, and inflammatory bowel diseases.

The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies.

In addition, it engages in the operation of a network of retail pharmacy stores. The company was incorporated in 1994 and is headquartered in Shanghai, China.

Shanghai Pharmaceuticals Holding Co., Ltd
Country China
Founded 1994
Industry Medical Distribution
Sector Healthcare
Employees 48,164
CEO Bo Shen

Contact Details

Address:
Shanghai Pharmaceutical Building
Shanghai, 200020
China
Phone 86 21 6373 0908
Website sphchina.com

Stock Details

Ticker Symbol 601607
Exchange Shanghai Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE000000C82
SIC Code 5122

Key Executives

Name Position
Qiuhua Yang Executive Chairman
Bo Shen President, Chief Financial Officer, Head of the Accounting Department and Executive Director
Yongzhong Li Vice President and Executive Director
Ming Dong Executive Director
Tao Zhong Vice President, Board Secretary and Joint Company Secretary
Dongming Li Vice President
Shuai Shao Vice President
Dr. Shunjiang Yu Chief Medical Officer
Pui Kiu Wong Joint Company Secretary
Ying Ke Director and General Manager of Research & Development Management Center